Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- carbamazepine
- Diflucan (fluconazole)
Interactions between your drugs
carBAMazepine fluconazole
Applies to: carbamazepine, Diflucan (fluconazole)
MONITOR: Coadministration with fluconazole may increase the plasma concentrations of drugs that are substrates of CYP450 3A4. The mechanism is decreased clearance due to inhibition of CYP450 3A4-mediated metabolism by fluconazole, a moderate inhibitor of the isoenzyme. A 30% increase in serum carbamazepine has been observed during coadministration with fluconazole according to the product labeling. There have also been a few isolated case reports in the medical literature describing an approximate doubling of carbamazepine levels following the addition of fluconazole, resulting in toxicity. Other drugs metabolized by CYP450 3A4 whose plasma levels reportedly are increased by fluconazole include oral contraceptives (ethinyl estradiol and levonorgestrel), cyclosporine, tacrolimus, and cisapride. These interactions have usually been observed with higher dosages of fluconazole (200 mg/day or more).
MANAGEMENT: Caution is advised when fluconazole is used with medications that undergo metabolism by CYP450 3A4, particularly those with a narrow therapeutic range. Dosage adjustments as well as clinical and laboratory monitoring may be appropriate for some drugs whenever fluconazole is added to or withdrawn from therapy.
References (18)
- Sugar AM, Saunders C, Idelson BA, Bernard DB (1989) "Interaction of fluconazole and cyclosporine." Ann Intern Med, 110, p. 844
- Canafax DM, Graves NM, Hilligoss DM, et al. (1991) "Interaction between cyclosporine and fluconazole in renal allograft recipients." Transplantation, 51, p. 1014-8
- Torregrosa V, De la Torre M, Campistol JM, et al. (1992) "Interaction of fluconazole with ciclosporin A." Nephron, 60, p. 125-6
- Barbara JA, Clarkson AR, LaBrooy J, et al. (1993) "Candida albicans arthritis in a renal allograft recipient with an interaction between cyclosporin and fluconazole." Nephrol Dial Transplant, 8, p. 263-6
- (2002) "Product Information. Diflucan (fluconazole)." Roerig Division
- Lopez-Gil JA (1993) "Fluconazole-cyclosporin interaction: a dose-dependent effect?" Ann Pharmacother, 27, p. 427-30
- Baciewicz AM, Baciewicz FA, Jr (1993) "Ketoconazole and fluconazole drug interactions." Arch Intern Med, 153, p. 1970-6
- Assan R, Fredj G, Larger E, Feutren G, Bismuth H (1994) "FK 506/fluconazole interaction enhances FK 506 nephrotoxicity." Diabete Metab, 20, p. 49-52
- Osowski CL, Dix SP, Lin LS, Mullins RE, Geller RB, Wingard JR (1996) "Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients." Transplantation, 61, p. 1268-72
- Bedford TA, Rowbotham DJ (1996) "Cisapride: drug interactions of clinical significance." Drug Saf, 15, p. 167-75
- Sinofsky FE, Pasquale SA (1998) "The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives." Am J Obstet Gynecol, 178, p. 300-4
- Nair DR, Morris HH (1999) "Potential fluconazole-induced carbamazepine toxicity." Ann Pharmacother, 33, p. 790-2
- Dresser GK, Spence JD, Bailey DG (2000) "Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition." Clin Pharmacokinet, 38, p. 41-57
- Michalets EL, Williams CR (2000) "Drug interactions with cisapride: clinical implications." Clin Pharmacokinet, 39, p. 49-75
- Hilbert J, Messig M, Kuye O, Friedman H (2001) "Evaluation of interaction between fluconazole and an oral contraceptive in healthy women." Obstet Gynecol, 98, p. 218-23
- Ulivelli M, Rubegni P, Nuti D, Bartalini S, Giannini F, Rossi S (2004) "Clinical evidence of fluconazole-induced carbamazepine toxicity." J Neurol, 251, p. 622-3
- Tsouli S, Maranis S, Kyritsis AP (2011) "Fluconazole-carbamazepine interaction in a patient with bipolar disorder." Psychiatry Clin Neurosci, 65, p. 112
- Finch CK, Green CA, Self TH (2002) "Fluconazole-carbamazepine interaction." South Med J, 95, p. 1099-100
Drug and food interactions
carBAMazepine food
Applies to: carbamazepine
GENERALLY AVOID: Alcohol may potentiate some of the pharmacologic effects of carbamazepine. Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.
In a small, randomized, crossover study, the administration of carbamazepine with grapefruit juice (compared to water) increased plasma drug concentrations by approximately 40%. The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.
MANAGEMENT: Patients receiving carbamazepine should be advised to avoid or limit consumption of alcohol. Given the drug's narrow therapeutic index, patients receiving carbamazepine therapy should preferably avoid the regular consumption of grapefruits and grapefruit juice to prevent any undue fluctuations in plasma drug levels. Patients should be advised to report signs of carbamazepine toxicity (nausea, visual disturbances, dizziness, or ataxia) to their physicians.
References (3)
- (2002) "Product Information. Tegretol (carbamazepine)." Novartis Pharmaceuticals
- Garg SK, Kumar N, Bhargava VK, Prabhakar SK (1998) "Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy." Clin Pharmacol Ther, 64, p. 286-8
- Bailey DG, Dresser GR, Kreeft JH, Munoz C, Freeman DJ, Bend JR (2000) "Grapefruit-felodipine interaction: Effect of unprocessed fruit and probable active ingredients." Clin Pharmacol Ther, 68, p. 468-77
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Caplyta
Caplyta is used to treat schizophrenia or depression associated with bipolar disorder. It is taken ...
Vraylar
Vraylar is a once a day antipsychotic medication used to treat mental health or mood disorders ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Abilify
Abilify is an antipsychotic medicine used to treat the symptoms of schizophrenia and bipolar ...
Seroquel
Seroquel is used to treat the symptoms of schizophrenia, bipolar disorder and major depressive ...
Prozac
Prozac (fluoxetine) is an SSRI antidepressant used to treat depression, OCD, panic disorder ...
Lyrica
Lyrica is used to control seizures, treat nerve pain and fibromyalgia. Learn about side effects ...
Lamictal
Lamictal is an anti-epileptic medication used treat seizures in adults and children over 2 years ...
Depakote
Depakote is used to treat various types of seizure disorders. Learn about side effects ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.